Inhibitex Inc.
This article was originally published in Start Up
Executive Summary
Preventing bacteria from initially binding to host tissue is an attractive strategy for prophylactic and therapeutic intervention in infectious diseases. Inhibitex Inc. thinks it can do just that, using its knowledge of microbial surface components recognizing adhesive matrix molecules (MSCRAMMs).